Publicaties

Kenniscentrum
Jaar
Auteur

Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels

Schirmbeck, F., Konijn, M., Hoetjes, V., Zink, M. & De Haan, L.
Verschenen in European Archives of Psychiatry and Clinical Neuroscience, 269, 245-255 (2019)

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

Guloksuz, S., Pries, L.K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D., De Haan, L., GROUP Researchers & van Os, J.
Verschenen in World Psychiatry, 18(2), 173-182 (2019)

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study

Menghini-Müller, S., Studerus, E., Ittig, S., Heitz, U., Egloff, L., Andreou, C., Valmaggia, L.R., Kempton, M.J., van der Gaag, M., De Haan, L. & et al.
Verschenen in European Psychiatry, 59, 52-59 (2019)

Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients

van der Pluijm, M., Sutterland, A.L., van Kullenbrog, A.B.P., Zoetekouw, L., De Haan, L., Booij, J. & van de Giessen, E.
Verschenen in Therapeutic Advances in Psychopharmacology, 9, 1-7 (2019)

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use

Ferraro, L., La Cascia, C., Quattrone, D., Sideli, L., Matranga, D., Cappucio, V., WP2 EU-GEI Group, De Haan, L. & di Forti, M., et al.
Verschenen in Schizophrenia Bulletin, Volume 46, Issue 3, 517–529 (2019)

The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al

Vermeulen, J.M., Schirmbeck, F. & Blankers, M.
Verschenen in American Journal of Psychiatry, 176, 575-576 (2019)

Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity

Berendsen, S., van der Veen, N.M., van Tricht, M.J. & De Haan, L.
Verschenen in Schizophrenia Research, 216, 416-421 (2019)

Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder

Chandran, D., Robbins, D.A., Chang, C.K., Shetty, H., Sanyal, J., Downs, J., Fok, M., Ball, M., Jackson, R., Stewart, R., Cohen, R., Vermeulen, J.M., Schirmbeck, F., De Haan, L. & Hayes, R.
Verschenen in Scientific Reports, 9, 14146, 1-7 (2019)

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years

Vermeulen, J.M., van Rooijen, G., van de Kerkhof, M.P.J., Sutterland, A.L., Correll, C.U. & De Haan, L.
Verschenen in Schizophrenia Bulletin, Volume 45, Issue 2, 315-329 (2019)

Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial

Pos, K., Franke, N., Smit, F., Wijnen, B.F.M., Staring, A.B.P., van der Gaag, M., Meijer, C., De Haan, L., Velthorst, E. & Schirmbeck, F.
Verschenen in Journal of Consulting and Clinical Psychology, 87 (2), 151–160 (2019)

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis

Cakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P.J., De Haan, L., Bahn, S., Penninx, B.W.J.H. & van Beveren, N.J.M.
Verschenen in European Neuropsychopharmacology, Volume 29, Issue 7, 835-846 (2019)

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Alqarni, A., Todd, W.M., McGorry, P.D., Nelson, B., Markulevm C., Yuen, H.P., Schäfer, M.R., De Haan, L., Meyera, B.J. & et. al.
Verschenen in Schizophrenia Research, Volume 226, 44-51 (2019)

Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis

Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J., De Haan, L., Pijnenborg, G.H.M. & et al.
Verschenen in Frontiers in Psychiatry, 10, 345 (2019)

Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis

Wijnen, B.F.M., Thielen, F.W., Konings, S., Feenstra, T., van der Gaag, M., Veling, W., De Haan, L., Ising, H., Hiligsman, M., Evers, S.M.A.A., Smit, F. & Lokkerbol, J.
Verschenen in Expert Review of Pharmacoeconomics & Outcomes Research, Volume 20, 2020, Issue 3, 269-279 (2019)

Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study

Vermeulen, J.M., Wootton, R.E., Treur, J.L., Sallis, H.M., Jones, H.J., Zammit, S., van den Brink, W., Goodwin, G.M., De Haan, L. & Munafo, M.R.
Verschenen in The British Journal of Psychiatry, Volume 218 , Issue 2, 88 - 94 (2019)

Exploring construct validity of clinical staging in schizophrenia spectrum disorders in an acute psychiatric ward

Berendsen, S., van der Paardt, J., van Bruggen, M., Nusselder, H., Jalink, M., Peen, J., Van, H., Dekker, J.J.M. & De Haan, L.
Verschenen in Clinical Schizophrenia & Related Psychoses (2018)

Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study

Swets, M., van Dijk, F.A., Schirmbeck, F., Peen, J., De Haan, L., Alizadeh, B.Z. & van Winkel, R.
Verschenen in Psychiatry Research, 271, 421-427 (2018)

Validity of police contacts as a performance indicator for the public mental health care system in Amsterdam: an open cohort study

Lauriks, S., Buster, M.C.A., de Wit, M.A.S., Arah, O.A., Hoogendoorn, A.W., Peen, J. & Klazinga, N.S.
Verschenen in Social Psychiatry and Psychiatric Epidemiology, 53, 577–586 (2018)

Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk

Hagen, J., Sutterland, A.L., Koeter, M.W.J., Lutter, R., Cohn, D.M. & De Haan, L.
Verschenen in The Journal of Clinical Psychiatry (2017)
ISO 9001 HKZNEN7510 Keurmerk

Disclaimer | Privacyverklaring | Cookiebeleid | © 2024 Arkin Onderzoek - Alle rechten voorbehouden | Realisatie: Lemon

Arkin